Proposed Data Collection Submitted for Public Comment and Recommendations, 55543-55545 [2018-24234]
Download as PDF
<![CDATA[
khammond on DSK30JT082PROD with NOTICES
Federal Register / Vol. 83, No. 215 / Tuesday, November 6, 2018 / Notices
(11) Under an order of a court of
competent jurisdiction; and
(12) To a consumer reporting agency,
when trying to collect a claim of the
Government, in accordance with 31
U.S.C. 3711(e).
In addition, in accordance with
paragraph (3) above, the ‘‘routine uses’’
set forth in paragraphs (13) through (24)
below shall apply to all records in all
FTC Privacy Act systems of records.
Specifically, such records:
(13) Where appropriately
incorporated into the records
maintained in FTC–II–6 (Discrimination
Complaint System–FTC), may be
disclosed under the routine uses
published for that system;
(14) May be disclosed to the National
Archives and Records Administration
for records management inspections
conducted under authority of 44 U.S.C.
2904 and 2906;
(15) May be disclosed to other
agencies, offices, establishments, and
authorities, whether federal, state, local,
foreign, or self-regulatory (including,
but not limited to organizations such as
professional associations or licensing
boards), authorized or with the
responsibility to investigate, litigate,
prosecute, enforce, or implement a
statute, rule, regulation, or order, where
the record or information by itself or in
connection with other records or
information:
(a) Indicates a violation or potential
violation of law, whether criminal, civil,
administrative, or regulatory in nature,
and whether arising by general statute
or particular program statute, or by
regulation, rule, or order issued
pursuant thereto, or
(b) Indicates a violation or potential
violation of a professional, licensing, or
similar regulation, rule, or order, or
otherwise reflects on the qualifications
or fitness of an individual who is
licensed or seeking to be licensed;
(16) May be disclosed to any source,
private or governmental, to the extent
necessary to secure from such source
information relevant to and sought in
furtherance of a legitimate investigation
or audit;
(17) May be disclosed to any
authorized agency component of the
Federal Trade Commission, Department
of Justice, or other law enforcement
authorities, and for disclosure by such
parties:
(a) To the extent relevant and
necessary in connection with litigation
in proceedings before a court or other
adjudicative body, where (i) the United
States is a party to or has an interest in
the litigation, including where the
agency, or an agency component, or an
agency official or employee in his or her
VerDate Sep<11>2014
17:05 Nov 05, 2018
Jkt 247001
official capacity, or an individual
agency official or employee whom the
Department of Justice has agreed to
represent, is or may likely become a
party, and (ii) the litigation is likely to
affect the agency or any component
thereof; or
(b) To obtain advice, including advice
concerning the accessibility of a record
or information under the Privacy Act or
the Freedom of Information Act;
(18) May be disclosed to a
congressional office in response to an
inquiry from that office made at the
written request of the subject
individual, but only to the extent that
the record would be legally accessible to
that individual;
(19) May be disclosed to debt
collection contractors for the purpose of
collecting debts owed to the
government, as authorized under the
Debt Collection Act of 1982, 31 U.S.C.
3718, and subject to applicable Privacy
Act safeguards;
(20) May be disclosed to a grand jury
agent pursuant either to a federal or
state grand jury subpoena, or to a
prosecution request that such record be
released for the purpose of its
introduction to a grand jury, where the
subpoena or request has been
specifically approved by a court;
(21) May be disclosed to the Office of
Management and Budget (OMB) for the
purpose of obtaining advice regarding
agency obligations under the Privacy
Act, or in connection with the review of
private relief legislation pursuant to
OMB Circular A–19;
(22) To appropriate agencies, entities,
and persons when (a) the FTC suspects
or has confirmed that there has been a
breach of the system of records; (b) the
FTC has determined that as a result of
the suspected or confirmed breach there
is a risk of harm to individuals, the FTC
(including its information systems,
programs, and operations), the Federal
Government, or national security; and
(c) the disclosure made to such
agencies, entities, and persons is
reasonably necessary to assist in
connection with the FTC’s efforts to
respond to the suspected or confirmed
breach or to prevent, minimize, or
remedy such harm.
(23) To another Federal agency or
Federal entity, when the FTC
determines that information from this
system of records is reasonably
necessary to assist the recipient agency
or entity in (a) responding to a
suspected or confirmed breach or (b)
preventing, minimizing, or remedying
the risk of harm to individuals, the
recipient agency or entity (including its
information systems, programs, and
operations), the Federal Government, or
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
55543
national security, resulting from a
suspected or confirmed breach.
(24) May be disclosed to FTC
contractors, volunteers, interns or other
authorized individuals who have a need
for the record in order to perform their
officially assigned or designated duties
for or on behalf of the FTC.
The routine uses contained in this
Appendix are in addition to any routine
uses contained in the system of records
notice (SORN) for each FTC Privacy Act
records system. Some of the authorized
disclosures and routine uses may
overlap with one another. The FTC will
treat a routine use as valid and still in
effect, even if an overlapping routine
use or disclosure is partly or fully
invalidated or repealed.
Heather Hippsley,
Deputy General Counsel.
[FR Doc. 2018–24226 Filed 11–5–18; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Toxic Substance and
Disease Registry
[60Day–19–0048; Docket No. ATSDR–2018–
0009]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Agency for Toxic Substance
and Disease Registry, Department of
Health and Human Services (HHS)
ACTION: Notice with comment period.
AGENCY:
The Agency for Toxic
Substance and Disease Registry, as part
of its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled ATSDR Exposure Investigations
(EIs) (OMB Control No. 0923–0048,
Expiration Date 3/31/2019)—
Extension—Agency for Toxic
Substances and Disease Registry
(ATSDR). To evaluate public health
issues at a site resulting from
environmental exposure, ATSDR EIs fill
data gaps by conducting environmental
and biological sampling.
DATES: CDC must receive written
comments on or before January 7, 2019.
SUMMARY:
E:\FR\FM\06NON1.SGM
06NON1
55544
Federal Register / Vol. 83, No. 215 / Tuesday, November 6, 2018 / Notices
You may submit comments,
identified by Docket No. ATSDR–2018–
0009 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
khammond on DSK30JT082PROD with NOTICES
ADDRESSES:
VerDate Sep<11>2014
17:05 Nov 05, 2018
Jkt 247001
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
ATSDR Exposure Investigations (EIs)
(OMB Control No. 0923–0048,
Expiration Date 3/31/2019)—
Extension—Agency for Toxic
Substances and Disease Registry
(ATSDR).
Background and Brief Description
The Agency for Toxic Substances and
Disease Registry (ATSDR) is requesting
a three-year Paperwork Reduction Act
approval for the extension of the generic
clearance titled ATSDR Exposure
Investigations (OMB No. 0923–0048;
OMB Exp. Date: 3/31/2019) to allow the
agency to conduct exposure
investigations (EIs), through methods
developed by ATSDR.
After a chemical release or suspected
release into the environment, EIs are
usually requested by officials of a state
health agency, county health
departments, the Environmental
Protection Agency (EPA), the public,
and ATSDR staff.
EI results are used by public health
professionals, environmental risk
managers, and other decision makers to
determine if current conditions warrant
intervention strategies to minimize or
eliminate human exposure. For
example, four of the EIs that ATSDR
conducted in the past three years
include the Anaconda Smelter (MT—
blood lead and urine arsenic), Former
United Zinc and Associated Smelters
(KS—blood lead), Dimock Private Well
Water Sampling (PA) and Follow-up
arsenic urine testing in Hayden,
Arizona.
Example 1: Anaconda Smelter Blood
Lead and Urine Arsenic Sampling, MT
The site is a former smelter located in
Anaconda, Montana. Past smelting
activities resulted in high levels of
heavy metals, primarily arsenic and
lead, in community soil and in the slag
piles. ATSDR sampled blood and urine
in community members to evaluate lead
(blood) and arsenic (urine). Given
community concern about
contamination, all members of the
community were invited to participate
in the testing.
Urine samples were evaluated for
total arsenic, speciated arsenic (organic
and inorganic), creatinine and specific
gravity. If arsenic is detected, speciation
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
of the sample will determined whether
the arsenic is organic (probably
resulting from eating seafood) or
inorganic (likely resulting from
exposure to environmental arsenic). The
results of the testing are currently being
analyzed by the National Center for
Environmental Health/Division of
Laboratory Sciences (NCEH/DLS).
Results will be sent individually to
participants when the analysis is
completed and a report will be prepared
and presented to the community in a
community meeting.
Example 2: Former United Zinc and
Associated Smelters Blood Lead
Testing, Iola, Kansas
The community is located in the
vicinity of the Former United Zinc and
Associated Smelters in Iola, Kansas. The
smelters operated from 1902 to 1925
and operations resulted in heavy metal
contamination in community soils.
Limited sampling of the community in
the past found elevated blood lead
levels in young children. The blood
testing was completed in two phases:
One in December of 2016 and one in
August 2017 and a total of 61
participants were tested: 24 Children
younger than 6 years, 17 children aged
6–19 years and 20 adult women. One
child younger than 6 years had a BLL
greater than 5 mg/dL. The child’s parents
were notified by phone of the results by
the ATSDR Medical Officer and follow
up was conducted by the local PEHSU
(Pediatric Environmental Health
Specialty Unit.
All participants received their results
by mail and the EI report was released
and presented to the community in a
public meeting in August 2018.
Example 3: Private Well Water
Sampling in Dimock, Pennsylvania
Unconventional natural gas drilling
activities have been conducted in the
Dimock, PA area for approximately 10
years and local residents complain of
poor water quality. In 2012, EPA
sampled 64 private wells in the area for
contaminants that may be present due to
natural gas drilling activities. ATSDR
assisted in the analysis of the 2012 data
set and the following recommendations
were made:
Æ People with elevated levels of
inorganic analytes in their well water
should install a home treatment system,
and
Æ people with high levels of methane
in their well water should vent their
well and home and treat their water to
eliminate potential buildup of explosive
gases.
E:\FR\FM\06NON1.SGM
06NON1
55545
Federal Register / Vol. 83, No. 215 / Tuesday, November 6, 2018 / Notices
Example 4: Follow-Up Arsenic Urine
Testing in Hayden, Arizona
ATSDR completed an EI in 2015 at
the ASARCO Hayden Smelter Site in
Hayden, AZ. The EI included blood lead
and urine arsenic testing. Air
monitoring determined that the smelter
was not operating during the sample
collection period and that, given the
short half-life of arsenic in the body, the
arsenic results may not be valid.
In 2017, ATSDR retested the
participants from the 2015 EI to evaluate
their urinary arsenic levels. It was
determined that all urinary arsenic
levels were below the follow-up level
and air data indicate that air arsenic
levels in the 2 weeks prior to testing
were consistent with usual levels seen
in the community. The EI report is being
prepared and a community meeting will
be held when the document is released.
Additional water sampling was
recommended and an EI was conducted
in August in 2017. For the EI, the 64
residents previously sampled were
invited to have their private wells
ATSDR also collects information on
other possible confounding sources of
chemical(s) exposure such as medicines
taken, foods eaten, hobbies, jobs, etc. In
addition, ATSDR asks questions on
recreational or occupational activities
that could increase a participant’s
exposure potential. That information
represents an individual’s exposure
history.
The number of questions can vary
depending on the number of chemicals
being investigated, the route of exposure
(e.g., breathing, eating, touching), and
number of other sources of the
chemical(s) (e.g., products used, jobs).
We use approximately 12–20 questions
about the pertinent environmental
exposures per investigation.
Typically, the number of participants
in an individual EI ranges from 10 to
100. Participation is completely
voluntary, and there are no costs to
participants other than their time. Based
on a maximum of 12 EIs per year and
100 participants each, the estimated
annualized burden hours are 600.
retested: 25 residences agreed
participate in the EI sampling. Residents
were provided the results of their
sampling and an EI report is currently
being prepared. It will be presented to
the community in a public meeting
when completed.
All of ATSDR’s targeted biological
assessments (e.g., urine, blood) and
some of the environmental
investigations (e.g., air, water, soil, or
food sampling) involve participants to
determine whether they are or have
been exposed to unusual levels of
pollutants at specific locations (e.g.,
where people live, spend leisure time,
or anywhere they might come into
contact with contaminants under
investigation).
Questionnaires, appropriate to the
specific contaminant, are generally
needed in about half of the EIs (at most
approximately 12 per year) to assist in
interpreting the biological or
environmental sampling results. ATSDR
collects contact information (e.g., name,
address, phone number) to provide the
participant with their individual results.
ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)
Number of
responses per
respondent
Total burden
(in hours)
Form name
Exposure Investigation Participants ..
Chemical Exposure Questions .........
1,200
1
30/60
600
Total ...........................................
...........................................................
........................
........................
........................
600
Jeffrey M. Zirger,
Acting Lead, Information Collection Review
Office, Office of Scientific Integrity, Office
of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2018–24234 Filed 11–5–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–19–18APJ]
Agency Forms Undergoing Paperwork
Reduction Act Review
khammond on DSK30JT082PROD with NOTICES
Number of
respondents
Type of respondents
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Surveillance of
Nonfatal Injuries Among On-Duty Law
Enforcement Officers to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
VerDate Sep<11>2014
17:05 Nov 05, 2018
Jkt 247001
Submitted for Public Comment and
Recommendations’’ notice on July 20,
2018 to obtain comments from the
public and affected agencies. CDC
received one comment related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
Surveillance of Nonfatal Injuries
Among On-Duty Law Enforcement
Officers—New—National Institute for
Occupational Safety and Health
E:\FR\FM\06NON1.SGM
06NON1
]]>Agencies
- DEPARTMENT OF HEALTH AND HUMAN SERVICES
- Agency for Toxic Substance and Disease Registry
[Federal Register Volume 83, Number 215 (Tuesday, November 6, 2018)]
[Notices]
[Pages 55543-55545]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-24234]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Toxic Substance and Disease Registry
[60Day-19-0048; Docket No. ATSDR-2018-0009]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Agency for Toxic Substance and Disease Registry, Department of
Health and Human Services (HHS)
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Agency for Toxic Substance and Disease Registry, as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled ATSDR Exposure Investigations
(EIs) (OMB Control No. 0923-0048, Expiration Date 3/31/2019)--
Extension--Agency for Toxic Substances and Disease Registry (ATSDR). To
evaluate public health issues at a site resulting from environmental
exposure, ATSDR EIs fill data gaps by conducting environmental and
biological sampling.
DATES: CDC must receive written comments on or before January 7, 2019.
[[Page 55544]]
ADDRESSES: You may submit comments, identified by Docket No. ATSDR-
2018-0009 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
ATSDR Exposure Investigations (EIs) (OMB Control No. 0923-0048,
Expiration Date 3/31/2019)--Extension--Agency for Toxic Substances and
Disease Registry (ATSDR).
Background and Brief Description
The Agency for Toxic Substances and Disease Registry (ATSDR) is
requesting a three-year Paperwork Reduction Act approval for the
extension of the generic clearance titled ATSDR Exposure Investigations
(OMB No. 0923-0048; OMB Exp. Date: 3/31/2019) to allow the agency to
conduct exposure investigations (EIs), through methods developed by
ATSDR.
After a chemical release or suspected release into the environment,
EIs are usually requested by officials of a state health agency, county
health departments, the Environmental Protection Agency (EPA), the
public, and ATSDR staff.
EI results are used by public health professionals, environmental
risk managers, and other decision makers to determine if current
conditions warrant intervention strategies to minimize or eliminate
human exposure. For example, four of the EIs that ATSDR conducted in
the past three years include the Anaconda Smelter (MT--blood lead and
urine arsenic), Former United Zinc and Associated Smelters (KS--blood
lead), Dimock Private Well Water Sampling (PA) and Follow-up arsenic
urine testing in Hayden, Arizona.
Example 1: Anaconda Smelter Blood Lead and Urine Arsenic Sampling, MT
The site is a former smelter located in Anaconda, Montana. Past
smelting activities resulted in high levels of heavy metals, primarily
arsenic and lead, in community soil and in the slag piles. ATSDR
sampled blood and urine in community members to evaluate lead (blood)
and arsenic (urine). Given community concern about contamination, all
members of the community were invited to participate in the testing.
Urine samples were evaluated for total arsenic, speciated arsenic
(organic and inorganic), creatinine and specific gravity. If arsenic is
detected, speciation of the sample will determined whether the arsenic
is organic (probably resulting from eating seafood) or inorganic
(likely resulting from exposure to environmental arsenic). The results
of the testing are currently being analyzed by the National Center for
Environmental Health/Division of Laboratory Sciences (NCEH/DLS).
Results will be sent individually to participants when the analysis is
completed and a report will be prepared and presented to the community
in a community meeting.
Example 2: Former United Zinc and Associated Smelters Blood Lead
Testing, Iola, Kansas
The community is located in the vicinity of the Former United Zinc
and Associated Smelters in Iola, Kansas. The smelters operated from
1902 to 1925 and operations resulted in heavy metal contamination in
community soils. Limited sampling of the community in the past found
elevated blood lead levels in young children. The blood testing was
completed in two phases: One in December of 2016 and one in August 2017
and a total of 61 participants were tested: 24 Children younger than 6
years, 17 children aged 6-19 years and 20 adult women. One child
younger than 6 years had a BLL greater than 5 [micro]g/dL. The child's
parents were notified by phone of the results by the ATSDR Medical
Officer and follow up was conducted by the local PEHSU (Pediatric
Environmental Health Specialty Unit.
All participants received their results by mail and the EI report
was released and presented to the community in a public meeting in
August 2018.
Example 3: Private Well Water Sampling in Dimock, Pennsylvania
Unconventional natural gas drilling activities have been conducted
in the Dimock, PA area for approximately 10 years and local residents
complain of poor water quality. In 2012, EPA sampled 64 private wells
in the area for contaminants that may be present due to natural gas
drilling activities. ATSDR assisted in the analysis of the 2012 data
set and the following recommendations were made:
[cir] People with elevated levels of inorganic analytes in their
well water should install a home treatment system, and
[cir] people with high levels of methane in their well water should
vent their well and home and treat their water to eliminate potential
buildup of explosive gases.
[[Page 55545]]
Example 4: Follow-Up Arsenic Urine Testing in Hayden, Arizona
ATSDR completed an EI in 2015 at the ASARCO Hayden Smelter Site in
Hayden, AZ. The EI included blood lead and urine arsenic testing. Air
monitoring determined that the smelter was not operating during the
sample collection period and that, given the short half-life of arsenic
in the body, the arsenic results may not be valid.
In 2017, ATSDR retested the participants from the 2015 EI to
evaluate their urinary arsenic levels. It was determined that all
urinary arsenic levels were below the follow-up level and air data
indicate that air arsenic levels in the 2 weeks prior to testing were
consistent with usual levels seen in the community. The EI report is
being prepared and a community meeting will be held when the document
is released.
Additional water sampling was recommended and an EI was conducted
in August in 2017. For the EI, the 64 residents previously sampled were
invited to have their private wells retested: 25 residences agreed
participate in the EI sampling. Residents were provided the results of
their sampling and an EI report is currently being prepared. It will be
presented to the community in a public meeting when completed.
All of ATSDR's targeted biological assessments (e.g., urine, blood)
and some of the environmental investigations (e.g., air, water, soil,
or food sampling) involve participants to determine whether they are or
have been exposed to unusual levels of pollutants at specific locations
(e.g., where people live, spend leisure time, or anywhere they might
come into contact with contaminants under investigation).
Questionnaires, appropriate to the specific contaminant, are
generally needed in about half of the EIs (at most approximately 12 per
year) to assist in interpreting the biological or environmental
sampling results. ATSDR collects contact information (e.g., name,
address, phone number) to provide the participant with their individual
results. ATSDR also collects information on other possible confounding
sources of chemical(s) exposure such as medicines taken, foods eaten,
hobbies, jobs, etc. In addition, ATSDR asks questions on recreational
or occupational activities that could increase a participant's exposure
potential. That information represents an individual's exposure
history.
The number of questions can vary depending on the number of
chemicals being investigated, the route of exposure (e.g., breathing,
eating, touching), and number of other sources of the chemical(s)
(e.g., products used, jobs). We use approximately 12-20 questions about
the pertinent environmental exposures per investigation.
Typically, the number of participants in an individual EI ranges
from 10 to 100. Participation is completely voluntary, and there are no
costs to participants other than their time. Based on a maximum of 12
EIs per year and 100 participants each, the estimated annualized burden
hours are 600.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Exposure Investigation Chemical 1,200 1 30/60 600
Participants. Exposure
Questions.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 600
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Acting Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2018-24234 Filed 11-5-18; 8:45 am]
BILLING CODE 4163-18-P
